Protein Therapeutics, Inc. Company Profile

12:11 EST 18th December 2018 | BioPortfolio

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (IgPO) to treat adult and juvenile rheumatoid arthritis, crippling diseases that affect more than 2.1 million people in the United States.Upon successful completion of this goal, Protein Therapeutics will explore other applications for immune replacement therapy, including Crohn's disease, ulcerative colitis, and autoimmune hearing loss


Suite 202, 2761 N. Country Club Road
United States of America


Phone: 520-574-1632
Fax: 520-844-1187

News Articles [1630 Associated News Articles listed on BioPortfolio]

2 Day Conference: Protein Design & Engineering – Bridging the Technological Gap Between Protein Evolution, Targeted Therapeutics and Analytical Techniques –

DUBLIN–(BUSINESS WIRE)–The “Protein Design & Engineering” conference has been added to’s offering. Protein-based drugs are a fast-growing clas...

Protein degradation start-up Kymera partners with GSK

Kymera Therapeutics Inc (protein degradation) entered into a two-year discovery collaboration with GlaxoSmithKline PLC to develop a limited number of protein degradation targets for novel drugs.

New Paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-Based Therapeutics

Sartorius Stedim Biotech (SSB) today announced a new paper entitled, ‘Shortening Timelines for Upstream Bioprocessing of Protein-based Therapeutics’ has been published in the journal, ...

Anima Biotech: Translation Control Therapeutics

Anima Biotech is pioneering Translation Control Therapeutics, a new class of drugs that control protein translation. Yochi Slonim discusses with Fintan Walton thier novel drug discovery platform that ...

Imaging atomic structure of important immune regulator

A new study provides a biophysical and structural assessment of a critical immune regulating protein called human T-cell immunoglobulin and mucin domain containing protein-3 (hTIM-3). Understanding th...

Sanofi and Denali Therapeutics Partner to Develop Treatments for Neurological and Inflammatory Diseases

PARIS, France – November 1, 2018 – Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to treat a range of neurological a...

Medical News Today: How much protein is too much?

Eating a high protein diet has many advantages for health. There are times, however, when a person may consume more protein than is healthy, especially if they have certain medical conditions. Consumi...

SmartZyme spin-off Carnot teams up with HemoShear

SmartZyme BioPharma Inc. has spun off its protein engineering platform into a new company named Carnot BioSciences LLC to collaborate with HemoShear Therapeutics LLC on the development of protein-base...

PubMed Articles [2447 Associated PubMed Articles listed on BioPortfolio]

Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations.

Protein therapeutics represent a rapidly growing proportion of new medicines being developed by the pharmaceutical industry. As with any new drug, an Occupational Exposure Limit (OEL) should be develo...

Critical considerations for immunocapture enrichment LC-MS bioanalysis of protein therapeutics and biomarkers.

In recent years, immunocapture enrichment coupled with LC-MS technology has seen more applications for the measurement of low abundant protein therapeutics and biomarkers in biological matrices. In th...

A Combined Computer-Aided Approach to Drive the Identification of Potential Epitopes in Protein Therapeutics.

The identification of fragment sequences, or motifs, within a therapeutic protein that may elicit an immune response when processed by T-cells can be provided by computer-aided approaches. Immunogenic...

Metal-Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics.

Protein therapeutics are prone to lose their structure and bioactivity under various environmental stressors. This study reports a facile approach using a nanoporous material, zeolitic imidazolate fra...

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct.

The advent of therapeutic mRNAs significantly increases the possibilities of protein-based biologics beyond those that can be synthesized by recombinant technologies (eg, monoclonal antibodies, extrac...

Clinical Trials [2352 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Role of Dietary Protein Intake in Elderly Adults

The investigators examined the effects of dietary protein intake in a mixed meal at two levels of protein amount on whole body protein metabolisms in older adults.

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients

In this study, we will explore the feasibility of doing a randomized controlled trial in our Intensive care department, King Abdulaziz Medical City, Riyadh which will test a two-step appro...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1965 Associated Companies listed on BioPortfolio]

Perlan Therapeutics

Perlan Therapeutics is an innovative developer of protein-based pharmaceuticals. The company's proprietary Multi-Valenceâ„¢ technology platform is the basis for the development of cost-effective p...


Since 1997, Xencor has built the most powerful protein engineering technology platform in the biotechnology industry. Its versatility is evidenced by our success in developing two classes of superior ...

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (Ig...

PX’Therapeutics SA

PX’Therapeutics, located in Grenoble and Lyon (France) and with a sales office in Cambridge (MA, USA), offers early stage research and cGMP manufacturing contracts focusing o...

Proteostasis Therapeutics

Proteostasis Therapeutics is discovering “Proteostasis Regulators” (PRs), small molecule drugs that restore proper protein function to treat neurodegenerative, metabolic...

More Information about "Protein Therapeutics, Inc." on BioPortfolio

We have published hundreds of Protein Therapeutics, Inc. news stories on BioPortfolio along with dozens of Protein Therapeutics, Inc. Clinical Trials and PubMed Articles about Protein Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Protein Therapeutics, Inc. Companies in our database. You can also find out about relevant Protein Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Corporate Database Quicklinks

Searches Linking to this Company Record